Holen Sie sich die Stockscreener-App
6.545
1.43%
-0.095
Schlusskurs vom Vortag:
$6.64
Offen:
$6.68
24-Stunden-Volumen:
77,712
Relative Volume:
0.28
Marktkapitalisierung:
$327.01M
Einnahmen:
$13.55M
Nettoeinkommen (Verlust:
$-25.32M
KGV:
-12.08
EPS:
-0.542
Netto-Cashflow:
-
1W Leistung:
-0.38%
1M Leistung:
+7.83%
6M Leistung:
+14.82%
1J Leistung:
+0.00%
1-Tages-Spanne:
$6.385
$6.91
1-Wochen-Bereich:
$6.29
$7.208
52-Wochen-Spanne:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Firmenname
Capsovision Inc
Sektor
Branche
Telefon
(408) 370-4790
Adresse
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.545 | 331.76M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.11 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.83 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.84 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.75 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Roth Capital | Buy |
| 2025-07-28 | Eingeleitet | The Benchmark Company | Speculative Buy |
Capsovision Inc Aktie (CV) Neueste Nachrichten
CapsoVision (CV) Q1 2026 Earnings: EPS Miss Raises Concerns Amid Operational UncertaintyProfitability Analysis - Newser
CapsoVision Inc. (CV) Gains 1.77% as Shares Test Key Resistance Near $7.23Community Pattern Alerts - Newser
CapsoVision Inc. (CV) Advances 1.18% as Price Moves Toward ResistanceHot Momentum Watchlist - Newser
CapsoVision (CV) Q1 2026 Miss: What Went WrongConsensus Beat Rate - Newser
CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026 - MSN
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
U.S. Smart Pills Market to Reach USD 619.10 Million by 2033 as - openPR.com
CapsoVision, Inc. (CV) AI-Powered Stock Analysis - Meyka
CapsoVision Reports Stable Q1 Revenue and Expands AI Medical Pipeline - HarianBasis.co
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 - Investing.com UK
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 By Investing.com - Investing.com South Africa
CapsoVision Q1 Earnings Call Highlights - sharewise.com
CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading - ChartMill
CAPSOVISION ($CV) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings call transcript: CapsoVision misses Q1 2026 EPS forecast, stock rises - Investing.com
Transcript: CapsoVision Q1 2026 Earnings Conference Call - Benzinga
CapsoVision Q1 2026 Earnings Call Transcript - MarketBeat
CapsoVision Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CapsoVision, Inc 1Q 2026: Revenue $2.79M, EPS $(0.15) — 10-Q Summary - TradingView
CapsoVision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CapsoVision Reports First Quarter 2026 Financial Results - Yahoo Finance UK
CapsoVision, Inc.Common Stock (Nasdaq:CV) Stock Quote - FinancialContent
User | times-online.comCapsoVision, Inc.Common Stock (Nasdaq:CV) Stock Quote - FinancialContent
CapsoVision Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
TradingKey - TradingKey
Number of shareholders of CapsoVision, Inc. – NASDAQ:CV - TradingView
Number of shareholders of CapsoVision, Inc. – DUS:H6U - TradingView
Earnings Preview: CapsoVision to Report Financial Results Post-market on May 14 - Moomoo
What makes CapsoVision (CV) different from its competitors? (Breakout Watch) 2026-05-07Delta Trends - newser.com
CapsoVision (NASDAQ: CV) amendment reports 5.10M shares owned by Harari group - Stock Titan
CapsoVision (CV) sales head exercises 107,357 options, boosts share stake - Stock Titan
CapsoVision (CV) price target decreased by 16.00% to 10.71 - MSN
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 - GlobeNewswire
CapsoVision (CV) 2026 proxy: director elections, Baker Tilly ratification and pay - Stock Titan
Capsule Endoscope Systems Market Climbs to USD 0.6 Billion - openPR.com
CapsoVision (CV) Stock Outlook | Q4 2025: EPS Tops ViewsUser Trade Ideas - Newser
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership - Yahoo Finance
CV (CapsoVision) reports far narrower Q4 2025 loss than estimates, shares stay flat in today’s trading.Net Margin - Cổng thông tin điện tử Tỉnh Sơn La
[EFFECT] CapsoVision, Inc SEC Filing - Stock Titan
CapsoVision (NASDAQ: CV) registers 2.87M PIPE shares for resale - Stock Titan
CapsoVision (CV) Stock Initiates Position (Froths) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
CapsoVision (CV) Stock Signal Based Trade (+11.30%) 2026-04-18Stock Distribution - Cổng thông tin điện tử Tỉnh Sơn La
Capsovision Incfiles prospectus for resale of 2,867,089 common shares by selling stockholdersSEC filing - marketscreener.com
Existing holders of CapsoVision (NASDAQ: CV) register 2.87M PIPE shares for resale - Stock Titan
Ching Hang Shen Net Worth (2026) - GuruFocus
CapsoVision (CV) ownership: Shen Ching Hang holds 6.40M shares, Star One indirect - Stock Titan
Finanzdaten der Capsovision Inc-Aktie (CV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Capsovision Inc-Aktie (CV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Atkinson Douglas Patrick | Head of Global Sales |
May 05 '26 |
Option Exercise |
0.57 |
34,786 |
19,692 |
107,357 |
| Harari Michele | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
59,043 |
| GOUW JULIA S | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Imperial Joanne Carol | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| King Wen-Herng Henry | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
23,597 |
| Kuo Hui Ying | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
13,241 |
| Tsai Chen Lung | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Petersen Rebecca Ann | Director of Clinical Affairs |
Aug 18 '25 |
Option Exercise |
0.37 |
24,834 |
9,097 |
24,834 |
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):